Navigation Links
Oncolytics Biotech(R) Inc. Announces Investment in Private Biotechnology Company
Date:10/20/2009

m and the Company's belief as to the potential of REOLYSIN as a cancer therapeutic, involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue Research and Development projects, the efficacy of REOLYSIN as a cancer treatment, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize REOLYSIN, uncertainties related to the research and development of pharmaceuticals, uncertainties related to the regulatory process and general changes to the economic environment. Investors should consult the Company's quarterly and annual filings with the Canadian securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue reliance on forward-looking statements. The Company does not undertake to update these forward-looking statements, except as may be required pursuant to applicable securities laws.

SOURCE Oncolytics Biotech Inc.


'/>"/>
SOURCE Oncolytics Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
7. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
11. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... June 03, 2015 GEA's Panther™ ... which is a standalone, fully-equipped laboratory unit that is ... limited productions in pilot plants. The Panther™ NS3006L achieves ... compact design allows for easy installation with simple operation, ... This homogenizer can be used in many different industries, ...
(Date:6/3/2015)... 03, 2015 From smart street lighting ... part in enabling success in dealing with important Societal ... leaders helped bring focus to the role and further ... Photonics21 annual meeting last week in Brussels. ... held 28 and 29 May at the Hotel Le ...
(Date:6/2/2015)... - Shell today celebrated the North American launch of an ... exhibit the size of a city block in New ... and the public, and special appearances by industry leaders ... the best total engine protection by addressing three prominent ... corrosion. "With the launch of Shell V-Power ...
(Date:6/2/2015)... Global Stem Cells Group subsidiary Adimarket has been named ... the regeneration and repair of human organs and tissues. The ... expansion plans in Latin America, a commitment made to meet ... stem cell therapies. , Bioquark Inc. is ... to alter the regulatory state of human tissues and organs, ...
Breaking Biology Technology:GEA Announces the Panther™ NS3006L, a Self-Contained, Fully-Equipped Laboratory Homogenizer Well Suited for Pilot Plants 2Photonics21 Annual Meeting Focuses on Solutions for ‘Societal Challenges’ 2Photonics21 Annual Meeting Focuses on Solutions for ‘Societal Challenges’ 3New Shell V-Power NiTRO+ Premium Gasoline Introduces Breakthrough Formulation for BEST TOTAL Engine Protection 2New Shell V-Power NiTRO+ Premium Gasoline Introduces Breakthrough Formulation for BEST TOTAL Engine Protection 3New Shell V-Power NiTRO+ Premium Gasoline Introduces Breakthrough Formulation for BEST TOTAL Engine Protection 4Adimarket Named Latin American Distributor for Bioquark Biologic Products for the Regeneration and Repair of Human Organs and Tissue with Stem Cells 2Adimarket Named Latin American Distributor for Bioquark Biologic Products for the Regeneration and Repair of Human Organs and Tissue with Stem Cells 3
... the air-conditioning bill, middle class families in Wisconsin - and ... cost of energy. It's simply outrageous that it now costs ... continues to allow the oil companies to rack up record ... facing an energy crisis. It's a crisis of affordability for ...
... has received permission to continue trading company stock while it ... , ,Merge, a developer of medical imaging and information management ... it to continue listing its common stock subject to a ... The company was unable to comply with filing requirements by ...
... Silicon Pastures will invest $195,000 in St. ... next-generation credit card processor that does not use a ... to look beyond the state's borders, and Pehr Anderson, ... arrived at the right time and in the right ...
Cached Biology Technology:Wisconsin can lead the way to energy independence 2Wisconsin can lead the way to energy independence 3
(Date:5/29/2015)... Research and Markets ( http://www.researchandmarkets.com/research/2w6zgs/facial ) ... Recognition Market by Solution, by Software, by Hardware, ... report to their offering. The ... become more efficient and cost effective. This has ... from the commercial sector. The development of 3D ...
(Date:5/27/2015)... May 27, 2015   Codonics ... systems and image documentation solutions and ... technologically-advanced automation solutions, is pleased to announce ... Codonics® Safe Label System® (SLS), an award-winning ... with the Omnicell Anesthesia Workstation, helps prevent ...
(Date:5/25/2015)... 25, 2015  Australia,s market for wearable technologies is ... saw the advent of several trials and prototypes. The ... is expected to ignite interest in wearables as well ... Australia . This in turn will spur greater ... new partnerships amongst vendors and distributors. ...
Breaking Biology News(10 mins):Global advanced Facial Recognition Market Expected to Grow From $2.77 Billion in 2015 to $6.19 Billion in 2020, at an Estimated CAGR of 17.4% 2Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4
... The U.S. Department of Homeland,Security (DHS) ... additional,fingerprints from international visitors arriving at Orlando ... the department,s upgrade from two-,to 10-fingerprint collection ... more accurately and efficiently establishing and verifying,visitors, ...
... FLAGSTAFF, Ariz. (Feb. 14, 2008) -- When scientists around the ... Mead, a researcher at Northern Arizona University, is one of ... the poop to prove it. "You have got to ... Laboratory of Quaternary Paleontology. "Although I don,t think anyone is ...
... Humans live in the midst of a seething, breathing ... and exotic, from the surface of the human skin, ... floors. Despite the powerful and pervasive role ... world remains a mystery. This is the subject of ...
Cached Biology News:DHS Begins Collecting 10 Fingerprints From International Visitors at Orlando International Airport 2Dung happens and helps scientists 2Dung happens and helps scientists 3Unexplored microbes hold incredible potential for science and industry 2Unexplored microbes hold incredible potential for science and industry 3